Literature DB >> 15967902

Short-term outcomes with small intestinal submucosa for ventral abdominal hernia.

W Scott Helton1, Piero M Fisichella, Robert Berger, Santiago Horgan, Nocif Joseph Espat, Herand Abcarian.   

Abstract

HYPOTHESIS: A bioabsorbable tissue scaffold of porcine submucosal small intestine extracellular matrix (Surgisis Gold [SIS]; Cook Biotech Inc, West Lafayette, Ind) mesh is safe and effective for ventral hernia repair.
DESIGN: Retrospective case series at a university teaching hospital. PATIENTS: Fifty-three consecutive patients having 8-ply SIS mesh repair of ventral abdominal hernias. MAIN OUTCOME MEASURES: Early complications, reoperation, hernia recurrence, mesh or wound infection, or reaction. Outcomes reported and compared on an intention-to-treat basis.
RESULTS: Patients were stratified by wound class: clean, clean-contaminated and contaminated, or dirty. Median follow-up was 14 months (range, 2-29 months) during which there were 22 complications (41%), 17 early reoperations (32%), 13 partial dehiscences (21%), 6 mesh reactions (11%), and 9 recurrent hernias (17%). Seven recurrent hernias (78%) in critically ill, patients with dirty wounds had the SIS mesh removed owing to infection or reoperation. In patients without SIS mesh removal or debridement, 1 (2.2%) of 44 developed a recurrent hernia at 6 months. Patients with dirty wounds were more likely to need early reoperation (P<.001), develop a complication (P<.01), partial wound dehiscence (P<.05), or recurrent hernia (P<.01) compared with patients with clean wounds. Critically ill patients were more likely to have hernia recurrence (P<.05), early reoperation (P<.001), and postoperative complications (P<.05).
CONCLUSIONS: Eight-ply SIS mesh is safe in clean and clean-contaminated hernia repair with satisfactory short-term outcomes. However, delayed wound infection, repeated operation, and mesh debridement warrant cautious use of SIS mesh in critically ill patients and those with dirty wounds.

Entities:  

Mesh:

Year:  2005        PMID: 15967902     DOI: 10.1001/archsurg.140.6.549

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  55 in total

1.  Anastomotic sealing by extracellular matrices (ECM) improves healing of colonic anastomoses in the critical early phase.

Authors:  Jens Hoeppner; Bettina Wassmuth; Goran Marjanovic; Sylvia Timme; Ulrich Theodor Hopt; Tobias Keck
Journal:  J Gastrointest Surg       Date:  2010-03-31       Impact factor: 3.452

2.  Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  Cherif Boutros; Ponandai Somasundar; N Joseph Espat
Journal:  World J Surg Oncol       Date:  2010-08-20       Impact factor: 2.754

Review 3.  A novel tool to evaluate bias in literature on use of biologic mesh in abdominal wall hernia repair.

Authors:  J Con; L Zarain; S Gogna; D J Samson; K Prabhakaran; S Gashi; E Tilley; R Latifi
Journal:  Hernia       Date:  2019-04-08       Impact factor: 4.739

4.  Not all biologics are equal!

Authors:  B C Shah; M M Tiwari; M R Goede; M J Eichler; R R Hollins; C L McBride; J S Thompson; D Oleynikov
Journal:  Hernia       Date:  2010-12-28       Impact factor: 4.739

5.  The outcome of newborns with abdominal wall defects according to the method of abdominal closure: the experience of a single center.

Authors:  João Gilberto Maksoud-Filho; Uenis Tannuri; Marcos Marques da Silva; João Gilberto Maksoud
Journal:  Pediatr Surg Int       Date:  2006-05-12       Impact factor: 1.827

6.  The use of Surgisis for abdominal wall reconstruction in the separation of omphalopagus conjoined twins.

Authors:  Roshni Dasgupta; Paul W Wales; Ronald M Zuker; David M Fisher; Jacob C Langer
Journal:  Pediatr Surg Int       Date:  2007-09       Impact factor: 1.827

7.  Comparison of biological and alloplastic meshes in ventral incisional hernia repair.

Authors:  A Koscielny; S Widenmayer; T May; J Kalff; P Lingohr
Journal:  Langenbecks Arch Surg       Date:  2017-12-06       Impact factor: 3.445

8.  Impact of pericardium bovine patch (Tutomesh(®)) on incisional hernia treatment in contaminated or potentially contaminated fields: retrospective comparative study.

Authors:  A Gurrado; I F Franco; G Lissidini; G Greco; M De Fazio; A Pasculli; A Girardi; G Piccinni; V Memeo; M Testini
Journal:  Hernia       Date:  2014-03-01       Impact factor: 4.739

Review 9.  Biological Implant for Complex Abdominal Wall Reconstruction: A Single Institution Experience and Review of Literature.

Authors:  Elsa Limura; Pasquale Giordano
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

10.  Use of botulinum toxin type a before abdominal wall hernia reconstruction.

Authors:  Tomas R Ibarra-Hurtado; Carlos M Nuño-Guzmán; Jorge E Echeagaray-Herrera; Everardo Robles-Vélez; José de Jesús González-Jaime
Journal:  World J Surg       Date:  2009-09-22       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.